文献速递腹部技术与安全CT

以患者为中心评估口服对比剂的价值

Patient-Centered Assessment of the Value of Oral Contrast Material.
PubMed 文献 · J Am Coll Radiol · 2017-08-30

该前瞻性调查研究在两家门诊中心连续纳入接受腹盆部CT口服对比剂的患者,于2016年8月30日至2017年3月9日发放问卷,应答率93%(218/234)。89%(193/218)的患者表示即使可选择不喝,也会因担心漏诊重要发现而始终饮用口服对比剂;55%(120/218)认为味道可耐受,17%(36/218)出现担忧或不适。

要点

  • 89%(193/218)的门诊患者表示即使可选择不喝,也会因担心漏诊重要发现而始终饮用口服对比剂。
  • 仅5例(2%)表示无论风险如何都绝不饮用口服对比剂。
  • 55%(120/218)认为口服对比剂味道可耐受,10%(21/218)认为差或极差。

核心结论

  • 若口服对比剂具有任何诊断获益,大多数门诊患者(89%)宁愿饮用也不愿接受漏诊重要发现的任何风险。

研究设计与样本

  • 前瞻性、符合HIPAA的调查研究,于2016年8月30日至2017年3月9日在两家门诊中心对连续门诊患者在口服对比剂后立即发放问卷,共234例,应答218例(93%),完成率100%(218/218)。

诊断标准与关键数值

  • 应答率93%(218/234),完成率100%(218/218)。
  • 89%(193/218)表示始终会饮用口服对比剂;5例(2%)表示绝不饮用;20例(9%)表示取决于风险水平。
  • 18例(8%)表示若不需饮用口服对比剂,可接受0.01%至1.00%的漏诊重要发现风险。
  • 55%(120/218)认为味道可耐受,10%(21/218)认为差或极差。
  • 36例(17%)在得知需饮用口服对比剂时感到担忧或不安(8例极轻、15例轻度、10例中度、3例极重);36例(17%)出现口服对比剂所致恶心或腹部不适(10例极轻、15例轻度、10例中度、1例极重)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to measure the value of oral contrast material from the patient's point of view.

METHODS: A prospective HIPAA-compliant survey was administered from August 30, 2016, to March 9, 2017, at two outpatient centers to consecutive outpatients immediately after oral contrast material consumption for abdominopelvic CT. The survey included validated measures of temporary health disutility and oral contrast-specific questions vetted by patient advocates with experience in survey design. Descriptive statistics were calculated.

RESULTS: The response rate (93% [218 of 234]) and completion rate (100% [218 of 218]) were excellent. When given a hypothetical choice to not drink oral contrast, most subjects (89% [193 of 218]) stated that they would always drink it for fear of missing an important finding, and only 5 (2%) stated that they would never drink it regardless of risk. Twenty (9%) said that the decision to drink oral contrast would depend on the level of risk, with 18 (8%) indicating that they would accept a 0.01% to 1.00% risk for missing an important finding if they did not have to drink oral contrast. Most patients rated the oral contrast taste as tolerable (55% [120 of 218]); a minority rated it bad or terrible (10% [21 or 218]). Thirty-six subjects (17%) experienced concern or unease (8 minimal, 15 mild, 10 moderate, 3 extreme) when they learned that they had to drink oral contrast, and 36 (17%) experienced oral contrast-induced nausea or abdominal discomfort (10 minimal, 15 mild, 10 moderate, 1 extreme).

CONCLUSIONS: If oral contrast material has any diagnostic benefit, most outpatients (89%) would rather drink it than accept any risk for missing an important finding.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Woolen SA, Maturen KE, Nettles A, et al. Patient-Centered Assessment of the Value of Oral Contrast Material. J Am Coll Radiol. 2017. PMID: 28869127. doi:10.1016/j.jacr.2017.06.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。